SCHEMBL24813238

SCHEMBL24813238

c1ccc(-c2ccc(-c3ccc4c(c3)c3ccccc3n4-c3ccc(-c4ccc(-c5ccc6sc7ccccc7c6c5)cc4)cc3)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.46
ATM Q13315 2/20 0.46
KDM4E B2RXH2 1/20 0.46
GPR3 P46089 1/20 0.39
TSPO P30536 1/20 0.39
HDAC4 P56524 1/20 0.39
PIM3 Q86V86 1/20 0.39
LIMK1 P53667 1/20 0.36
HSD17B10 Q99714 1/20 0.36
CYP1A2 P05177 1/20 0.35
ALDH1A1 P00352 3/20 0.34
MAPT P10636 2/20 0.34
HPGD P15428 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
KMT2A Q03164 3/20 0.34
IL1R1 P14778 1/20 0.34
PTPN7 P35236 1/20 0.34
DUSP3 P51452 1/20 0.34
PTPN12 Q05209 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21365671 1.00 L3MBTL1 (0.46) L3MBTL1ATMKDM4EGPR3TSPO
SCHEMBL21151549 1.00 L3MBTL1 (0.46) L3MBTL1ATMKDM4EGPR3TSPO
SCHEMBL21578628 1.00 L3MBTL1 (0.46) L3MBTL1ATMKDM4EGPR3TSPO
SCHEMBL14212278 1.00 L3MBTL1 (0.46) L3MBTL1ATMKDM4EGPR3TSPO
SCHEMBL16901517 1.00 L3MBTL1 (0.46) L3MBTL1ATMKDM4EGPR3TSPO
SCHEMBL24173703 1.00 L3MBTL1 (0.46) L3MBTL1ATMKDM4EGPR3TSPO
SCHEMBL18779536 0.99 L3MBTL1 (0.49) L3MBTL1ATMKDM4EGPR3TSPO
SCHEMBL17661321 0.99 L3MBTL1 (0.49) L3MBTL1ATMKDM4EGPR3TSPO
SCHEMBL24813235 0.97 L3MBTL1 (0.44) L3MBTL1ATMKDM4EGPR3TSPO
SCHEMBL24810819 0.97 L3MBTL1 (0.44) L3MBTL1ATMKDM4EGPR3TSPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS PIEZO1, TMEM109, SLC39A14 L3MBTL1 1876/4885ATM 3436/4885KDM4E 3416/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.